Cell technologies in retinitis pigmentosa treatment
Akhmedyanova Z. Yeltokova M. Bayanbayeva Z. Khassenova A.
2022National Scientific Medical Center
Journal of Clinical Medicine of Kazakhstan
2022#19Issue 24 - 8 pp.
The growing crucial problem in practical ophthalmology relates to growth of hereditary degenerative diseases of the retina, in particular retinitis, causing progressive loss of visual functions. According to international estimates, the incidence rate of hereditary dystrophy contains 1 case per 3000 population. With the development of biomedical cell technologies, transplantation of stem (autologous and allogeneic) cells is at the stage of active research. The article reviewed literature sources on prevalence, risk factors, etiopathogenesis, diagnosis, clinical picture and treatment of retinitis pigmentosa.
clinic , diagnosis , etiology , pathogenesis , retinitis pigmentosa , treatment
Text of the article Перейти на текст статьи
Department of Eye Diseases, Astana Medical University, Astana, Kazakhstan
Department of Ophthalmology, National Scientific Medical Center, Astana, Kazakhstan
Department of Academic Quality Unit, School of Public Health, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of Eye Diseases
Department of Ophthalmology
Department of Academic Quality Unit
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026